Press release
Benazepril Hydrochloride Tablets Market Size And Global Industry Forecast 2034
Benazepril Hydrochloride Tablets Market
With the global burden of hypertension and chronic cardiovascular diseases on the rise, Benazepril Hydrochloride tablets-a widely prescribed ACE (angiotensin-converting enzyme) inhibitor-have become an essential component of modern antihypertensive therapy. This market is poised for steady growth, supported by an aging population, increasing diagnosis rates, and expanding access to affordable generics.
According to Exactitude Consultancy, the Global Benazepril Hydrochloride Tablets Market was valued at USD 745 million in 2023 and is projected to reach USD 1.43 billion by 2034, growing at a CAGR of 6.18% from 2024 to 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/reports/58835/global-benazepril-hydrochloride-tablets-market#request-a-sample
Market Overview: Affordable Heart Health Solutions in Demand
• 2024 Market Size Estimate: USD 790 million
• 2034 Forecast: USD 1.43 billion
• CAGR (2024-2034): 6.18%
• Key Drivers:
o Growing prevalence of hypertension and related conditions like chronic kidney disease (CKD)
o Increasing geriatric population requiring long-term cardiovascular treatment
o Favorable pricing and wide availability of generic benazepril tablets
o Rising public health initiatives for early detection and control of high blood pressure
• Challenges:
o Drug recalls and supply disruptions
o Side effects such as dry cough, dizziness, and hyperkalemia
o Shift toward combination therapies that may reduce standalone benazepril prescriptions
• Leading Players:
o Novartis AG
o Teva Pharmaceuticals
o Mylan (Viatris)
o Apotex Inc.
o Lupin Limited
o Aurobindo Pharma
o Cipla
o Torrent Pharmaceuticals
o Zydus Lifesciences
o Hikma Pharmaceuticals
Segmentation Analysis
By Dosage Strength:
• 5 mg
• 10 mg
• 20 mg
• 40 mg
By Indication:
• Hypertension
• Congestive Heart Failure (CHF)
• Diabetic Nephropathy
• Chronic Kidney Disease (CKD)
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Government Supply Schemes
By End User:
• Adults
• Geriatric Patients
• Pediatric (Off-label/Clinical Trials)
Segmentation Summary:
10 mg and 20 mg tablets account for the largest prescription volume due to their role in maintenance therapy. The hypertension segment dominates, but indications like diabetic nephropathy are emerging areas of demand. Retail and online pharmacies are expanding reach, especially in middle-income countries.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/58835/global-benazepril-hydrochloride-tablets-market
Regional Analysis
North America
• Leading regional market due to a high prevalence of hypertension, established generic drug infrastructure, and consistent reimbursement support.
• The U.S. drives the majority share with widespread access to benazepril via Medicare, Medicaid, and private insurers.
Europe
• Demand remains strong in Germany, France, and the UK due to aging populations and structured public healthcare systems.
• Growing shift toward generic medications and preventive cardiovascular care.
Asia-Pacific
• Fastest-growing market, led by India, China, and Japan.
• Rising middle-class population, healthcare awareness, and large hypertensive population are fueling generic drug consumption.
Latin America
• Brazil and Mexico show steady uptake, aided by national hypertension screening programs and price-controlled generics.
Middle East & Africa
• Market expansion driven by increasing cardiovascular burden and partnerships for essential drug access.
• Countries like South Africa, Saudi Arabia, and UAE are showing increased adoption of chronic care medications.
Regional Summary:
North America and Europe dominate in value, but Asia-Pacific will see the most significant growth through 2034 due to high disease prevalence and expanding generic manufacturing capabilities.
Market Dynamics
Key Growth Drivers
• Rising Global Hypertension Rates: Over 1.2 billion people globally suffer from hypertension, according to WHO, creating vast demand for affordable first-line therapies.
• Geriatric Demographics: Older adults are the primary consumers of ACE inhibitors, and their population is increasing across all regions.
• Cost-Effectiveness of Generics: Generic benazepril is widely available, with prices significantly lower than branded alternatives, encouraging mass adoption.
• Policy Support: Public health programs in emerging markets are promoting generic cardiovascular drugs to reduce healthcare burdens.
Key Challenges
• Side Effect Profile: Dry cough, dizziness, and kidney-related issues can lead to non-compliance or medication switching.
• Drug Recalls and API Shortages: Quality issues and recalls can temporarily disrupt the market and erode trust.
• Rising Preference for Combination Therapy: Fixed-dose combinations (e.g., benazepril + hydrochlorothiazide) may replace standalone use in some cases.
Latest Trends
• Shift Toward FDCs (Fixed Dose Combinations): Growing interest in two-in-one therapies for better compliance.
• Increased Online Pharmacy Sales: Particularly in North America and India, where digital health models are thriving.
• Pharmacogenetics in ACE Inhibitor Therapy: Efforts to personalize therapy based on genetic profiles are emerging in high-end markets.
• WHO and NGO Partnerships: Access-focused initiatives are pushing ACE inhibitors into underserved global regions.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=58835
Competitive Landscape
Top Manufacturers:
• Novartis (Lotensin brand): Initially developed branded benazepril; continues to influence global supply chains.
• Teva Pharmaceuticals, Mylan, and Apotex: Leading producers of generics with wide global distribution networks.
• Lupin, Cipla, Zydus, Aurobindo: Major Indian manufacturers exporting generics to regulated and semi-regulated markets.
• Torrent and Hikma Pharmaceuticals: Focus on regional strengths and competitive pricing.
Competitive Summary:
The market is highly fragmented and price-sensitive, with dominance by generic manufacturers. Competition is based on pricing, distribution, regulatory approvals, and consistent product quality. Long-term contracts with governments and pharmacy chains are common strategies.
Conclusion: Market Outlook and Strategic Opportunities
The Benazepril Hydrochloride Tablets Market is entering a phase of consistent and scalable growth, supported by global public health goals, aging populations, and the rise of value-based care.
This report is also available in the following languages : Japanese (CMP保持リング), Korean (베나제프릴 염산염 정제), Chinese (盐酸贝那普利片), French (Comprimés de chlorhydrate de bénazépril), German (Benazeprilhydrochlorid-Tabletten), and Italian (Compresse di cloridrato di benazepril), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/58835/global-benazepril-hydrochloride-tablets-market#request-a-sample
Our More Report:
Medium and Heavy-duty Truck Steering System
https://exactitudeconsultancy.com/reports/63642/global-medium-and-heavy-duty-truck-steering-system-market
Plasma Cleaners
https://exactitudeconsultancy.com/reports/63644/global-plasma-cleaners-market
Tile Levelling Kits
https://exactitudeconsultancy.com/reports/63646/global-tile-levelling-kits-market
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Benazepril Hydrochloride Tablets Market Size And Global Industry Forecast 2034 here
News-ID: 4112493 • Views: …
More Releases from Exactitude Consultancy
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors.
Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,…
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics.
Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced…
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression.
Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate…
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
